Are you a robotics manufacturer?
Claim your page to correct your specs and keep your listing current.
Robocath is a robotics company founded 2009, based in France, developing 1 robot primarily in the Surgical / Medical category.
CAPITAL & EVIDENCE
Robocath has no confirmed funding round on file and has 1 cited customer but no deployment on record.
Shipped
1customer cited
named in a public source · no deployment on record
- Rennes University Hospital· 2022surgicalroboticstechnology.com ↗
A deployment is recorded when a public source names both the customer and the robot, or the maker confirms it. Nothing here counts against Robocath.
In Surgical / Medical, CMR Surgical, BD Rowa and Catalia Health have deployment evidence on file.
Add a deployment →Smart robotic solutions for the treatment of cardiovascular diseases
Robocath develops smart robotic platforms for cardiovascular interventions. Key products include R-One, a fully integrated system for remote delivery and adjustment of guidewires and stents during percutaneous coronary intervention (PCI), with CE marking in Europe since 2019, and R-One+, launched in 2023 for coronary angioplasties. Operates in Europe with clinical trials in France for carotid stenting; partnered with MicroPort MedBot for R-ONE approval in China in 2024. Targets interventional cardiologists in hospitals treating cardiovascular diseases.
Active products
1
RoboIndex
57.36
RoboScore 57.36 + Momentum 0.00
Company facts
- HQ
- Rouen, France
- Founded
- 2009 · 17 yrs
- Employees
- 70
- Website
- www.robocath.com
- View profile ↗
RoboScore
57.36 RoboScore + 0.00 Momentum· Strong evidence
Products 65%, Depth 5%, Evidence 30% set the number, and every rated company has all three. Attention has no weight of its own — it is one of the two things Evidence is built from, and it can only ever add. Activity and Readiness describe the brand but never move it. A value we don't have reads —, never zero. Momentum is independently collected news coverage, worth at most 15 points and never a deduction — a maker we have heard nothing about keeps its full RoboScore. Claiming or paying moves nothing.
6 of 6 factors known. How it's calculated
Milestones
R-ONE vascular intervention robot received NMPA approval in China via MicroPort MedBot JV
Launched R-One+ robotic platform for coronary angioplasties
Completed CARE clinical trial showing 100% success in robotic carotid stenting
Launched R-One+ robotic platform
R-EVOLUTION clinical study results announced
R-One received CE marking in Europe for cardiovascular treatments
R-One received CE marking approval
Medical Training and Testing Center in Rouen acquired R-One robot
Press coverage
- MicroPort® MedBot™ JV's R-ONE®, the World's First Dual-Finger Grasp Mimic Vascular Intervention Robot, Receives Approval in China
MicroPort · Feb 2024
- Robocath's R-One System Studied in France for Robotic Carotid Stenting
EVToday · Oct 2023
- Robocath launches new robotic platform R-One+
Robocath · May 2023
- R-One Robotic Device for Interventional Cardiology Procedures
Medical Device Network
Public loss record
Consumer product alerts from this country reach the EU Safety Gate, which we read. Industrial, workplace and medical incidents never enter it, so a blank record says nothing about those.
Active products by Robocath
1 shown| # | Category | ||||
|---|---|---|---|---|---|
| 1 | ![]() | R-One | Surgical / Medical | 2018 | 65.2 |
Surgical / Medical buying guides
Industry Knowledge →
Surgical Robot Vendor Selection: Support Coverage, Software Upgrades, and Lifecycle
A surgical robot purchased today will be in your OR for 10–15 years. The support SLA, software upgrade path, end-of-life timeline, and field service model deter…

Pilot to Scale: Case Volume Thresholds for Surgical Robot ROI
Most surgical robot programs break even somewhere between 150 and 400 cases per year depending on platform, procedure mix, and reimbursement. The math is knowab…

Surgeon Training Curve and Proctoring: The 18-Month Onboarding Window
A surgeon's robotic learning curve runs 20–150 cases depending on procedure and prior experience. The proctoring structure, credentialing ladder, and OR efficie…
